{
    "pmcid": "10315470",
    "qa_pairs": {
        "How do nanobodies achieve cross-reactivity against multiple SARS-CoV-2 variants?": [
            "By binding to conserved epitopes on the virus.",
            "By targeting only the variable regions of the virus.",
            "By being engineered to change their binding sites frequently.",
            "By having a broader binding spectrum due to their larger size."
        ],
        "What are the key advantages of nanobodies over traditional antibodies in the context of SARS-CoV-2 treatment?": [
            "Nanobodies are highly stable, soluble, and can offer cross-reactivity against multiple variants.",
            "Nanobodies are larger, making them more effective at blocking viral entry.",
            "Nanobodies are less stable but more specific to a single variant.",
            "Nanobodies are more expensive to produce and have a shorter half-life."
        ],
        "What challenges are associated with the use of nanobodies in vivo according to the paper?": [
            "Ensuring their efficacy, particularly regarding their half-life and distribution.",
            "Overcoming their high immunogenicity compared to traditional antibodies.",
            "Addressing their instability in microbial production systems.",
            "Managing their inability to bind to conserved viral epitopes."
        ],
        "What is a potential application of nanobody-fusions mentioned in the paper?": [
            "Targeting specific open reading frames (ORFs) of the virus to interfere with replication.",
            "Increasing the size of nanobodies for better immune response.",
            "Reducing the production cost of nanobodies.",
            "Enhancing the solubility of traditional antibodies."
        ],
        "What is a significant focus of the paper regarding the interaction of SARS-CoV-2 with the host immune system?": [
            "Understanding the viral genome, replication cycle, immune activation, and antagonism.",
            "Exploring the nutritional impact on immune response.",
            "Investigating the role of gut microbiota in viral infection.",
            "Analyzing the effects of environmental factors on virus transmission."
        ]
    }
}